Delivery Order SPE2DB24D2010-SPE2DB25FABHX
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,451.98 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count units) under a firm fixed price contract. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and represents a non-competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,248.39 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,534.28 for 60 mg Brilinta tablets (60-count) on August 27, 2025, with completion scheduled for August 28, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 90 mg under a firm fixed price contract valued at $3,938.90, with completion scheduled for August 8, 2025. This non-set-aside delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs, likely for military or veteran healthcare systems managed through DLA's medical supply chain. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $5,118.70 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packaging) under a firm fixed-price contract type. The award was made on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a competitive award with no set-aside designation, reflecting open competition for the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Brilinta 60 mg tablets (quantity 60 count) valued at $1,664.52. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The order is due for completion by September 16, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. This award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages) under a firm fixed-price contract valued at $2,134.02. The order was competitively awarded without a set-aside designation and carries an ultimate completion date of July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,664.52 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages) under a firm fixed-price contract. The award was made on April 25, 2025, with an ultimate completion date of April 28, 2025. This non-set-aside contract represents a small-value transaction typical of the routine pharmaceutical procurement activities conducted through the agency's medical supply chain. Performance will be executed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) with a contract ceiling value of $1,741.14. This firm fixed price delivery order, with an ultimate completion date of September 24, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the location of performance—is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets (60-count) with a ceiling value of $1,116.90. This non-set-aside, competitively awarded contract is structured as a delivery order under a firm fixed-price arrangement, with an ultimate completion date of September 24, 2025. The award was issued on September 23, 2025, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FABHXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 mg Brilinta tablets (60-count units) valued at $69,968.50 with a firm fixed price structure. This non-set-aside contract, awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a routine pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor within the Defense Logistics Agency's medical supply chain, fulfilling pharmaceutical requirements across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support. The IDC enables AmerisourceBergen to supply a broad spectrum of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The arrangement reflects the Defense Logistics Agency's strategy to maintain flexible, competitively awarded contract vehicles with qualified pharmaceutical distributors capable of meeting diverse federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $70.0k | 9/23/25 |